サイケデリックのABC:薬物発見のための臨床前ロードマップ

Alex C Kwan¹, John R Mantsch², John D McCorvy³

¹Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.

Trends in pharmacological sciences

|August 28, 2025

まとめ

精神疾患に対する次世代のサイケデリック薬の開発には感受体選択性と治療効果を評価する枠組みが必要ですこのプロセスの鍵となるのは信号伝達,行動分析,神経再構築の進歩です

科学分野:

神経科学
精神薬学
薬物の発見

背景:

精神疾患に対するサイケデリック薬への関心が高まっています
理想的な受容体選択性と治療効果を持つ次世代のアナログを特定する課題
最近の進歩バイアス信号伝達行動現象型化神経再構成遺伝子発現

研究の目的:

サイケデリックと非幻覚性セロトニン2A (5-HT2A) 受容体アゴニストの評価のための枠組みを概説します.
アゴニズム,行動,細胞の可塑性を評価する現在の方法を批判的に検討する.
人間による翻訳の改善のための新興技術を強調します.

主な方法:

サイケデリック化合物の評価のための現在の方法論のレビュー.
アゴニスト誘発のバイアス信号伝導の評価
自動化されたビデオ分析による高内容の行動現象化
薬物による構造神経改造と活性依存遺伝子発現の分析

主要な成果:

サイケデリックと5-HT2Aアゴニストの評価のための枠組みが提案されています.
アゴニズム,行動,可塑性を評価するための現在の方法は批判的に検討されています.
人間による翻訳の可能性のある新興技術が強調されています.

結論:

効果的なサイケデリック薬の発見パイプラインは実験目標と一致しなければなりません
サイケデリック薬の開発に成功するには複数のアプローチを組み込むことが重要です
提案された枠組みは,新しいサイケデリック類の体系的な評価に役立つ.

キーワード:

Gタンパク質結合受容体バイアスアゴニスト神経の可塑性について部分的アゴニストスクリーニングセロトニン

さらに関連する動画

11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.5K

11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.6K

関連する概念動画

01:26

Drug Discovery: Overview

8.7K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

8.7K

01:28

Preclinical Development: Overview

4.8K

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

4.8K

01:22

CNS Stimulants: Psychedelic Agents

241

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

241

01:27

Hallucinogens and Psychedelics

282

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

282

01:28

An Overview of Psychoactive Drugs

294

Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...

294

01:26

Drug Administration and Therapy Phases: Overview

738

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

738

関連する実験動画